The Biogen Foundation's STAR Initiative--for Science, Teacher support, Access and Resources--is intended to strengthen and support educational offerings in these cities by helping increase access to STEM resources and opportunities for students currently underrepresented in STEM college or career pathways.
Through a coordinated network of grantees, STAR endeavors to help low-income students develop and sustain their interest in STEM, gain necessary STEM exposure and enrichment opportunities, and successfully transition into post-secondary education in pursuit of STEM careers.
The Biogen Foundation will soon be soliciting proposals from nonprofits providing services in the areas of STEM access, exploration, and preparedness for students in grades 6-12.
Successful applicants will partner with Cambridge and/or Somerville public schools by providing in- or out-of-school STEM awareness, exploration, and skill-building support and activities.
Organizations selected to receive grants will become part of a coordinated provider network managed by the Biogen Foundation. The STAR initiative is intended to complement, supplement, and strengthen the existing STEM education landscapes in Cambridge and Somerville.
The Biogen Foundation supports access to science education and to essential human services for children and their families in the communities in which Biogen facilities are located.
The foundation is committed to sparking a passion for science and discovery, supporting effective science education initiatives, and strengthening efforts to make science education and science careers accessible to diverse populations.
West Pharmaceutical Services declares quarterly dividend of USD0.22 per share
MedPal AI acquires eMARx to expand digital care home platform
Valerio Therapeutics signs R&D collaboration with Abivax and outlines pipeline milestones
Labcorp declares quarterly dividend of USD0.72 per share
Aptamer Group launches Optimer-based Ebola diagnostic programme
SK bioscience to lead Gates Foundation-funded ROTOR project
Nona Biosciences and Lonza collaborate on antibody-based BBB-crossing technology for CNS diseases
Lilly declares Q3 2026 dividend
Abbott declares quarterly dividend of USD0.63 per share
Gilead Sciences mobilises remdesivir donation to support Ebola response in Uganda
INOVIO's oartner ApolloBio reports positive topline results from Phase 3 trial of VGX-3100
Lilly declares Q2 2026 dividend
Collegium to acquire AZSTARYS from Corium Therapeutics
CVS Health announces quarterly dividend of USD0.665 per share
Convatec launches co-branded eakin freeseal ostomy seal in North America